See Change™ in Protein Characterization
University of Washington: Characterization of β-amyloid oligomers
Valerie Daggett, Professor of Bioengineering (primary), Biochemistry, Biomedical and Health Informatics, Chemical Engineering, Molecular Engineering, Neuroscience, and Biological Physics, Structure and Design
"We believe it [AQS3pro] can play a significant role in the protein characterization technology toolkit, overcoming shortcomings in existing techniques."
Next Generation in Protein Characterization
The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:
Aggregation | Quantitation | Stability | Structure | Similarity
See change in your protein, in your workflow, and in your efficiency.
Bioprocessing Summit, Aug 12-16, Boston MA
American Drug Delivery and Formulation Summit, Sep 9-10 Boston MA
Structural Biology, Oct 14-16, London UK
Well Characterized Biologics & Biological Assays, Nov 11-13, Reston, VA
MIBio Conference, Nov 13, Cambridge UK
PEGS Europe, Nov 18-22, Lisbon
RedShift™, RedShiftBio™, See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.